To ascertain contemporary overall and differential thirty-day mortality (TDM) rates after all types of nephrectomy in the UK, and to identify potential new risk factors for death.
Introduction
There is increasing focus on the outcomes of surgical procedures and the factors associated with those outcomes [1] . This information is important to surgeons, patients and policy-makers alike. In the UK this was highlighted in 2012 with the issuing of a government directive for specialist surgical associations to report publicly the outcomes of common surgical procedures [2] . The UK government directive was controversial but followed on from the largely successful initiatives in cardiothoracic surgery to publish outcomes openly [3] . The BAUS chose thirty-day mortality (TDM) after nephrectomy as the index outcome.
Knowing the risk of death and the reasons for it can be difficult. The literature suggests that surgical mortality after nephrectomy varies from 0.6 to 3.6%, with the lowest rates often being reported by large specialist centres [4] . The published literature has well documented limitations: there is a bias towards the publication of success because, in general, only teams with outstanding results present and publish [5] [6] [7] . Furthermore, some clinical scenarios may be very rare, which means an analysis of individual case series is of limited value when judging their frequency and significance. In this regard it would be much more useful to know the results across a much broader spectrum of surgeons, and ideally across a whole nation [8, 9] . A contemporary analysis of outcomes seems timely, given the widespread changes in nephrectomy practice over the last decade, such as the adoption of minimally invasive surgery, increased use of nephron-sparing surgery, and cytoreductive nephrectomy in the era of tyrosine kinase inhibitors.
In the first 3 years of data collection, BAUS surgeons have entered data on >20 000 nephrectomies. A detailed analysis of the deaths that occurred after these nephrectomies could potentially: (1) establish accurately the contemporary risk of death after all types of nephrectomy [10] ; (2) identify and quantify risk factors associated with death; and (3) help us to understand more clearly the relationship between volume and outcome in nephrectomy.
Materials and Methods
A national database of selected procedures has been maintained by BAUS since 2001. Participation in this database was optional until 2012, when a government directive made it compulsory to record the outcomes of a selected index procedure [11] . BAUS chose nephrectomy as the index operation and the existing BAUS database was modified to allow data entry on nephrectomy (e.g. ischaemia times, margins). All types of nephrectomy were included: radical, partial, cytoreductive, nephro-ureterectomy and simple nephrectomy.
BAUS members in England, Wales, Scotland and Northern Ireland entered data online on nephrectomies performed in 2012, 2013 and 2014. Data entry was mandatory in England and optional for Wales, Scotland and Northern Ireland. This dataset can be viewed at www.baus.org.uk/patients/surgical_ outcomes and covers a period between 1 January 2012 and 31 December 2014. Data were entered on 21 380 nephrectomies. The operations were performed by 321 surgeons in 122 hospitals. In total, this represented 86% of all nephrectomies performed in England when compared with Hospital Episode Statistics (HES) [12] . Complications were graded according to the Clavien-Dindo classification system. The BAUS initiated a retrospective analysis of data prospectively entered into the database to identify all deaths within 30 days of nephrectomy (TDM) and understand the risk factors behind those deaths. The latter was investigated using univariate and multivariate logistic regression analyses, whereby TDM was the main outcome of interest. The multivariate models were adjusted for age, sex, performance status (PS) and T stage. In addition, we studied TDM by surgeon and centre volume using mortality control charts.
Statistical analyses were conducted using SAS release 9.4 (SAS Institute, Cary, NC, USA) and Microsoft Excel. Institutional review board approval was exempted as these data form part of a compulsory National Audit run under the auspices of BAUS.
Results
Data on 21 380 nephrectomies were entered by 321 surgeons from 122 centres across the UK over the 3-year period. A total of 20 085 of the 22 824 (88%) nephrectomies performed in England were captured in this National Audit when compared with HES, which are available for England only. The majority (94%) of the data was entered by hand rather than being uploaded from a registry, for example, the Somerset Cancer Registry. The median (range) number of procedures per consultant was 13 The univariate and multivariate odds ratios (ORs) and 95% CIs for TDM are shown in Table 2 . The univariate analyses showed a statistically significant positive association with estimated blood loss (EBL) and transfusion, cytoreductive surgery, conversion, operating time, stage, age and PS. After adjustment for age, PS, T stage, and sex, these observations remained. The strongest associations were observed for EBL, conversion and technique: For instance, patients who lost between 2000 and 5000 mL of blood as compared with those who lost <500 mL had an OR of 3.92 (95% CI 1.52-10.13). This OR became 39.70 (95% CI 16.57-94.62) for those who lost >5000 mL blood during the surgery ( Table 2 ). The TDM rate was higher in the group with EBL of 1-2 L than in the group with EBL of 2-5 L (OR 1.38; 95% CI 1.03-2.24).
Those who underwent surgery with curative intent had a lower risk of TDM compared with those who underwent cytoreductive surgery (OR 0.31; 95% CI 0.18-0.54). An inverse association was noted for partial vs radical nephrectomy (OR 0.32; 95% CI 0.11-0.89).
Patients who underwent conversion to open surgery had a 2.53 higher risk of TDM, compared with those who did not (95% CI 1.41-4.51; Finally, we analysed TDM by surgeon and centre volume (Figs 1 and 2 ). The outliers above the 95% upper limit are those that were low-volume.
Discussion
The present study is based on an outstanding effort by an entire nation to prospectively and systematically determine the outcomes of all nephrectomy. Several elements suggest that surgeons in the UK are highly competent, including the following: the headline rate of death is 0.5% (110/21380); there has been safe introduction of minimal access surgery, which now comprises approximately two-thirds of procedures performed, with a mortality of 0.4% (59/14372); only four deaths were reported after 3931 partial nephrectomies (TDM 0.1%); and the mortality rate after nephrectomy for T3 disease was 0.8%. These are impressive results and stand comparison with rates published from the analysis of other large databases such as the National Cancer Institute Surveillance, Epidemiology, and End Results and the National Surgical Quality Improvement Program databases, which suggest overall mortality rates after nephrectomy of 0.9% and 1.13%. respectively [13, 14] .
The present study corroborates the importance of wellestablished risk factors associated with increased TDM: PS; T stage; EBL; and advanced age [4, [15] [16] [17] . For example, there was a fourfold increase in the risk of death for WHO PS 2 compared with PS 0, and a 16-fold increase between PS 4 and PS 0. The TDM rate after surgery for T4 tumours was 10-fold greater than for T1 and T2 tumours. Heavy EBL >5 L was associated with a 33-fold increased risk of death compared with EBL <500 mL.
The pan-national data in this study allow quantification of the contemporary risk of death after each type of nephrectomy, which could be valuable information for inclusion in the consent forms generated by BAUS and used as a benchmark against which individual surgeons may choose to measure themselves. The TDM rates after radical, partial and simple nephrectomy, and nephro-ureterectomy are 0.6% (63/11057), 0.1% (4/3931) and 0.4% (11/2819), and 0.9% (28/3091), respectively. The higher TDM rate after nephro-ureterectomy was significant on univariate but not multi-variate analysis, suggesting that the difference is likely to be attributable to patient comorbidity/PS rather than the operation itself or tumour characteristics. Minimally invasive surgery appears to have been introduced safely with no associated increase in mortality risk. Whilst EBL has previously been identified as a risk factor for death [4, 16] , the present study allows a more detailed analysis of the relationship between EBL and mortality. Intuitively, one might imagine that only very heavy EBL (e.g. >2 L) might be dangerous, but that does not appear to be the case. The present study suggests that an EBL of 1-2 L is more dangerous than EBL of 2-5 L. EBL of 1-2 L was associated with a sixfold increased risk of death compared with EBL <500 mL, whereas EBL of 2-5 L was associated with a fourfold increased risk. This seems counter-intuitive and may reflect the difficulty of estimating blood loss accurately; it may be that the 1-2 L category is too wide and the majority of cases in this category in fact have blood loss closer to 2 L than 1 L, or it may be that quite modest loss (1-2 L) may have adverse physiological consequences for patients but that such patients do not receive the same aggressive management as those with >2 L EBL would receive, e.g. transfusion, invasive monitoring and management in a high-dependency unit. More accurate measures of cardiac output during major surgery using trans-oesophageal Doppler might be the key to intra-operative monitoring of the physiological responses to EBL [18] .
The TDM rate in cases with conversion from minimally invasive to open surgery was significantly higher than in cases without conversion (OR 2.53; 95% CI 1.41-4.51). Possible explanations fall into three categories: the events leading to conversion; the quality of open nephrectomy then performed; and postoperative care [17, 19] . Common reasons for conversion include bleeding, adhesions and difficult dissection. It may be that, on occasion, a trial laparoscopic dissection was attempted to assess the feasibility of minimally invasive nephrectomy prior to planned conversion; there were 59/712 (8%) conversions because of the size of tumour. The BAUS Section of Oncology has commissioned a detailed review of the cases that were converted to open surgery so that we can make stronger recommendations about the safe management of such conversions. This is a research priority.
The relationship between volume of surgery and mortality is of interest but must be interpreted with caution. Several lowvolume surgeons and centres reported no deaths. Most surgeons/centres that reported deaths reported only one death, and one death inevitably looks more significant if the case volume is low. Equally, a surgeon/centre may have a clustering of deaths attributable to chance rather than underperformance [20] ; however, the likelihood of this is reduced over 3 years of data collection. The appropriate response to outliers is not clear but, without doubt, is an organizational priority for BAUS and is one of the main reasons the directive was issued by the government. Despite looking at a dataset of >20 000 nephrectomies, mortality is so low that it does not appear to provide a reliable measure of surgical quality or a basis for strong conclusions that might inform policy-making.
Limitations of the present study involve data capture, data entry and the endpoints measured. Firstly, cross-referencing with HES [12] , which are available for England only, suggests that we captured 20 085 of the 22 824 (88%) nephrectomies performed by English surgeons between 2012 and 2014 and 107 of the 166 deaths that occurred (64%). This could partly be attributed to the fact that only urologists contributed data to the BAUS audit, but HES data records nephrectomies performed by all surgeons, including transplant and trauma surgeons. Encouragingly, the data capture has improved from 78% in 2012 to 94% in 2013 and 86% in 2014, with 69% of deaths in the UK in 2014 captured compared with 58% in 2012.
Secondly, the data were surgeon-reported and all surgeons were mandated to provide it. Clinical epidemiologists question the value of surgeon-reported data, particularly with respect to the reporting of complications, but it seems surgeons are ideally placed to report operative data most effectively. The time-scale on the directive from the government for this first 2012 study was extremely short, with only 4 months from announcement of the initiative to the publication of results, and over the years the quality of data has and should continue to improve [3, 21] with reduction in the number of gaps in the data. In time, it may be that the quality of reports will be something that needs to be verified by independent auditors. Thirdly, it is not certain that mortality is the most valuable outcome to measure when addressing the quality and safety of nephrectomy in the UK. Whatever its merit as an endpoint, however, death is clinically relevant, verifiable and unarguable.
An overriding strength of the present study is the demonstration that meaningful national data entry is feasible and is a valuable tool, both for informing current practice and for improvement strategies within a surgical specialty. Hand entry of data, rather than from administrative datasets, is also likely to yield more meaningful conclusions. A future recommendation would be for a root-cause analysis to be carried out for all deaths in order to better understand all the individual patient, tumour and surgical factors involved in death from nephrectomy. As completeness of data improves it may also become possible to perform time-to-event analyses and generate predictive individual patient scores.
In conclusion, the present analysis of deaths occurring after nephrectomy in the UK over 3 years has given fresh fascinating insights into the risks of nephrectomy. It can help inform consent and provides contemporary TDM data for all types of nephrectomy. The quality of surgery in the UK appears to be high. In addition to confirming established risk factors, this study identifies surgery causing modest blood loss (1-2 L) and conversions to open surgery as areas of clinical and research priority. Those surgeons/ centres with the highest TDM rates appear to be those performing low-volume surgery. Outliers could be identified and assessed in an effort to improve national nephrectomy practice. 
